FDAFDA · Food and drugs·Recall number D-1424-2014
Labetalol Hydrochloride Injection, USP, 100 mg/20 mL (5 mg/mL), 20 mL Multidose Vial, packaged 50/20 mL glass vials/carton, Hospira, Inc., Lake Forest, IL 60045 --- NDC 0409-2267-20
Published July 16, 2014 · Recall initiated: May 16, 2014
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Presence of Particulate Matter; metal embedded in the glass vial and visible particles floating in the solution
What to do
Voluntary: Firm initiated · Press Release
Recall details
- Brand
- LABETALOL HYDROCHLORIDE
- Manufacturer
- Hospira Inc.
- Distributor
- Nationwide
- Lot
- Lot 36225DD, exp 12/01/2015
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Sell products like this?
Recalert watches your whole catalog for recalls like this one, automatically.